A group of Senate Democrats said they were willing to work with the incoming Trump administration to lower prescription drug prices and change the status quo.

In a letter to the president-elect, they urged Donald Trump to support legislation to restrict large price increases, and to give the HHS secretary the authority to negotiate prices under Medicare.

The senators also asked him to take executive measures requiring drug companies to disclose costs related to materials, manufacturing and research and development — and to list federal benefits received, including tax credits, grants and the government-funded research that their products are based on. The senators also called for Trump to task the Justice Department and the Federal Trade Commission with ensuring that generic drugs can reach the market.